Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists

Objective Parkinson's disease (PD) is characterized by the progressive degeneration of the nigrostriatal dopaminergic neurons. Rotigotine is a non-ergot dopamine receptor agonist (DA). Its transdermal patch maintains the effective concentrations for 24 hours. Freezing of gait (FOG) is a common...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Ken, Hirayama, Takehisa, Takazawa, Takanori, Kawabe, Kiyokazu, Iwasaki, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088535/
https://www.ncbi.nlm.nih.gov/pubmed/27725534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088535/
https://www.ncbi.nlm.nih.gov/pubmed/27725534

Ejemplares similares